Search details
1.
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.
Br J Clin Pharmacol
; 86(5): 944-957, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31856304
2.
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(4)2019 04.
Article
in English
| MEDLINE | ID: mdl-30745392
3.
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
J Antimicrob Chemother
; 74(3): 710-717, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30541077
4.
Intrapulmonary Pharmacokinetics of Relebactam, a Novel ß-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects.
Antimicrob Agents Chemother
; 62(3)2018 03.
Article
in English
| MEDLINE | ID: mdl-29311084
5.
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a ß-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.
Antimicrob Agents Chemother
; 62(9)2018 09.
Article
in English
| MEDLINE | ID: mdl-29914955
6.
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Hepatology
; 66(6): 1794-1804, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28688129
7.
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.
Arterioscler Thromb Vasc Biol
; 37(9): 1770-1775, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28729361
8.
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.
J Lipid Res
; 58(6): 1214-1220, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28314859
9.
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
Arterioscler Thromb Vasc Biol
; 36(5): 994-1002, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26966279
10.
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir.
Antimicrob Agents Chemother
; 59(11): 6922-9, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26303801
11.
Erratum for Rhee et al., "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a ß-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants".
Antimicrob Agents Chemother
; 62(12)2018 12.
Article
in English
| MEDLINE | ID: mdl-30478180
12.
Measurement of apo(a) kinetics in human subjects using a microfluidic device with tandem mass spectrometry.
Rapid Commun Mass Spectrom
; 27(12): 1294-302, 2013 Jun 30.
Article
in English
| MEDLINE | ID: mdl-23681806
13.
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.
J Pediatric Infect Dis Soc
; 12(12): 602-609, 2023 Dec 16.
Article
in English
| MEDLINE | ID: mdl-37815035
14.
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine
; 40(9): 1342-1351, 2022 02 23.
Article
in English
| MEDLINE | ID: mdl-35039194
15.
Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects.
Platelets
; 21(3): 191-8, 2010.
Article
in English
| MEDLINE | ID: mdl-20163197
16.
Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct-Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse-Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.
Clin Pharmacol Drug Dev
; 8(7): 962-970, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31173674
17.
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.
Clin Transl Sci
; 11(6): 553-561, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30040872
18.
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.
Clin Transl Sci
; 11(6): 562-572, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30040871
19.
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.
Clin Ther
; 40(5): 704-718.e6, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29703432
20.
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.
J Clin Invest
; 125(6): 2510-22, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25961461